LLY

924.69

+0.17%↑

UNH

589.75

-0.76%↓

NVO

137

+0.02%↑

JNJ

167.01

+0.91%↑

ABBV

195.83

+0.9%↑

LLY

924.69

+0.17%↑

UNH

589.75

-0.76%↓

NVO

137

+0.02%↑

JNJ

167.01

+0.91%↑

ABBV

195.83

+0.9%↑

LLY

924.69

+0.17%↑

UNH

589.75

-0.76%↓

NVO

137

+0.02%↑

JNJ

167.01

+0.91%↑

ABBV

195.83

+0.9%↑

LLY

924.69

+0.17%↑

UNH

589.75

-0.76%↓

NVO

137

+0.02%↑

JNJ

167.01

+0.91%↑

ABBV

195.83

+0.9%↑

LLY

924.69

+0.17%↑

UNH

589.75

-0.76%↓

NVO

137

+0.02%↑

JNJ

167.01

+0.91%↑

ABBV

195.83

+0.9%↑

Начало・Списък с акции・Bio-Rad Laboratories Inc

Bio-Rad Laboratories Inc

Затворен

Сектор Здравеопазване

326.06 1.47

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

323.5

Максимум

326.1

Ключови измерители
By Trading Economics
Приходи	-2.5B -2.2B
Продажби	28M 639M
EPS	3.11
Марж на печалбата	-339.153
Служители	8,030
EBITDA	-3.3B -2.7B

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+15.32 upside

Дивиденти
By Dow Jones
Следващи печалби	24.10.2024 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	65M 9.6B
Предишно отваряне	324.59
Предишно затваряне	326.06

Настроения в новините

By Acuity

50%

97 / 365 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Neutral Evidence

319.31 / 327.76 Подкрепа & съпротива

Bio-Rad Laboratories Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

14.09.2024 г., 01:45 ч. UTC

Печалби

Preview -- Barron's

13.09.2024 г., 20:03 ч. UTC

Топ новини

Walgreens to Pay $106.8 Million Over Alleged Fraudulent Healthcare Billings

15.09.2024 г., 23:47 ч. UTC

Пазарно говорене

Gold Edges Higher Amid Mild Dollar Weakness -- Market Talk

15.09.2024 г., 23:03 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

15.09.2024 г., 23:03 ч. UTC

Пазарно говорене

Australian Bond Traders Watchful as Fed Easing Nears -- Market Talk

15.09.2024 г., 16:52 ч. UTC

Топ новини

Boeing Machinist Strike Adds Cash Crunch to New CEO's Rescue Mission -- WSJ

15.09.2024 г., 09:30 ч. UTC

Топ новини

Interest Rates Are Too High. The Fed Should Cut by a Half Point. -- WSJ

15.09.2024 г., 07:00 ч. UTC

Топ новини

World's Biggest Hedge Fund Sells Apple, Eli Lilly Stock, and Buys Microsoft, Moderna -- Barrons.com

14.09.2024 г., 14:09 ч. UTC

Топ новини

Disney, DirecTV Reach Deal, Ending Blackout of ABC, ESPN -- Update 1 -- WSJ

14.09.2024 г., 13:25 ч. UTC

Топ новини

Disney, DirecTV Reach Deal, Ending Blackout of ABC, ESPN -- WSJ

14.09.2024 г., 09:30 ч. UTC

Топ новини

Why a Fed Rate Cut Won't Solve the Housing Wealth Gap -- WSJ

14.09.2024 г., 09:30 ч. UTC

Топ новини

Americans Are Falling Behind on Their Bills. Wall Street Is Alarmed. -- WSJ

14.09.2024 г., 03:00 ч. UTC

Топ новини

What Scared Ford's CEO in China -- WSJ

14.09.2024 г., 03:00 ч. UTC

Топ новини

What Scared Ford's CEO in China -- WSJ -2-

14.09.2024 г., 00:01 ч. UTC

Топ новини

Why 96% of Boeing's Machinists Voted to Go on Strike -- Update

13.09.2024 г., 21:14 ч. UTC

Топ новини

Why 96% of Boeing's Machinists Voted to Go on Strike -- WSJ

13.09.2024 г., 21:06 ч. UTC

Топ новини

Starliner Astronauts Say NASA Ran Short of Time to Test Boeing Craft -- WSJ

13.09.2024 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

13.09.2024 г., 20:47 ч. UTC

Пазарно говорене

Saudi Arabia Credit Outlook Raised to Positive on Economic Investments -- Market Talk

13.09.2024 г., 20:44 ч. UTC

Придобивния, сливания и поглъщания

Schlumberger Stock Was Once as Hot as Nvidia. Why It's a Buy. -- Barrons.com

13.09.2024 г., 20:41 ч. UTC

Топ новини

Berkshire Hathaway's Stock Is So Rich Even Berkshire Is Buying Less of It -- Update

13.09.2024 г., 20:31 ч. UTC

Печалби

These Stocks Moved the Most Today: Adobe, Boeing, Trump Media, Oracle, Uber, RH, Moderna, Etsy, and More -- Barrons.com

13.09.2024 г., 20:13 ч. UTC

Придобивния, сливания и поглъщания

BlackRock: Expects to Close Previously Announced Acquisition of Global Infrastructure Partners on Oct 1 >BLK

13.09.2024 г., 20:10 ч. UTC

Придобивния, сливания и поглъщания

BlackRock Announces Expected Closing Date For Acquisition Of Global Infrastructure Partners >BLK

13.09.2024 г., 20:02 ч. UTC

Придобивния, сливания и поглъщания

CGI Completes Acquisition Of Aeyon, Expands Capabilities For National Security And Civilian Agency Missions >GIB

13.09.2024 г., 20:02 ч. UTC

Придобивния, сливания и поглъщания

CGI Completes Acquisition Of Aeyon, Expands Capabilities For National Security And Civilian Agency Missions >GIB

13.09.2024 г., 19:44 ч. UTC

Пазарно говорене

Treasury Yields Fall as Odds of 50bp Fed Cut Rise -- Market Talk

13.09.2024 г., 19:20 ч. UTC

Пазарно говорене

Crude-Oil Futures End Week With Small Gains -- Market Talk

13.09.2024 г., 19:09 ч. UTC

Пазарно говорене

U.S. Natural-Gas Futures Post Weekly Gain -- Market Talk

13.09.2024 г., 18:01 ч. UTC

Пазарно говорене

Gold Analysts Call For New Leg Of Rally -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Bio-Rad Laboratories Inc Прогноза

Ценова цел

By TipRanks

15.32% нагоре

12-месечна прогноза

Среден 376.2 USD 15.32%

Висок 401 USD

Нисък 340 USD

Според 5 анализатори от Wall Street, предложили 12-месечна ценова цел за Bio-Rad Laboratories Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

5 ratings

Купи

Задържане

Продай

Според 5 анализатори, дали борсови рейтинги на Bio-Rad Laboratories Inc през последните 3 месеца.

Техническа оценка

By Trading Central

319.31 / 327.76Подкрепа & съпротива

The bullish and bearish events are balanced.

All events are bullish.

Bullish events outweigh bearish events.

Настроение

By Acuity

97 / 365 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and markets approximately 6,000 reagents, apparatus and laboratory instruments. Its products are used in research techniques, biopharmaceutical production processes and food testing regimes. Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market.